Adjunctive use of essential oils following scaling and root planing: a randomized clinical trial by Azad, Mohammad Fallah et al.
RESEARCH ARTICLE Open Access
Adjunctive use of essential oils following
scaling and root planing –a randomized
clinical trial
Mohammad Fallah Azad1, Andreas Schwiertz2 and Holger F. R. Jentsch3*
Abstract
Background: Hitherto no study has been published on the effect of the adjunctive administration of essential
oils following scaling and root planing (SRP). This study describes the effect of a mouthrinse consisting of essential
oils (Cymbopogon flexuosus, Thymus zygis and Rosmarinus officinalis) following SRP by clinical and microbiological
variables in patients with generalized moderate chronic periodontitis.
Methods: Forty-six patients (aged 40–65 years) with moderate chronic periodontitis were randomized in a
double-blind study and rinsed their oral cavity following SRP with an essential oil mouthrinse (n = 23) or placebo
(n = 23) for 14 days. Probing depth (PD), attachment level (AL), bleeding on probing (BOP) and modified sulcus
bleeding index (SBI) were recorded at baseline and after 3 and 6 months. Subgingival plaque was taken for
assessment of major bacteria associated with periodontitis.
Results: AL, PD, BOP and SBI were significantly improved in both groups after three (p < 0.001) and 6 months
(p ≤ 0.015). AL improved significantly better in the test than in the control group after 3 and 6 months (p < 0.001),
so did PD after three months in the tendency (p = 0.1). BOP improved better in the test group after 3 months
(p = 0.065). Numbers of Treponema denticola (p = 0.044) and Fusobacterium nucleatum (p = 0.029) decreased
more in the test than in the control group after 3 months, those of Tannerella forsythia after 6 months (p = 0.
039). Prevotella micra (p < 0.001,p = 0.035) and Campylobacter rectus (p = 0.002 ,p = 0.012) decreased significantly in
both groups after 3 months.
Conclusions: The adjunctive use of a mouthrinse containing essential oils following SRP has a positive effect on
clinical variables and on bacterial levels in the subgingival biofilm.
Trial registration: 332-12-24092012, DRKS 00009387, German Clinical Trials Register, Freiburg i. Br., 16.09.2015
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Background
Periodontitis is a multifactorial disease, meaning that a
single treatment approach is often not enough to combat
the bacterial colonisation [1]. The multi-causal etiology
of periodontal disease requires interdisciplinary treat-
ment concepts and the selection of a therapy that
focuses on the microbiological nature of the disease [2].
Currently, mechanical cleaning via scaling and root
planing (SRP) represents the method of choice [3],
which, through the removal of subgingival biofilm from
the root surface, leads to greater reduction of periodon-
topathogenic microorganisms. However, studies have
shown that remaining bacteria cannot be fully eliminated
and the adjunctive administration of antimicrobial sub-
stances is necessary [4, 5].
The variety of possible adjuvant periodontitis treat-
ment procedures includes local and systemic antibiotics
[6], photodynamic therapy [7, 8], Er:YAG lasers [9],
povidone-iodine [10, 11] as well as chlorhexidine diglu-
conate [12–14].
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To improve the outcome of SRP antibiotics are used
in severe forms of periodontitis [15, 16] and mostly
chlorhexidine rinsing is executed in the first days after
SRP [17, 18].
In the last two decades essential oils were extensively
tested regarding their antibacterial properties against a
broad spectrum of bacteria. Hammer et al. [19] investi-
gated also in vitro how tea tree oils alter the permeability
and membrane fluidity of different yeasts including
Candida albicans. Based on their results, it was assumed
that essential oils may have antimicrobial activity by in-
fluencing bacterial targets involved in cytoplasmatic and
membrane metabolism. Other in vitro studies displayed
that monoterpenes are important components of essen-
tial oils and increase fluidity and permeability of mem-
branes and thus disturb membrane proteins, resulting in
the inhibition of cell respiration and confusion of ion
transport processes [20].
Cymbopogon flexuosus oil (lemongrass oil) has in vitro
a strong antimicrobial and antifungal activity and in-
hibits very efficiently early biofilm formation [21, 22].
This oil elicites morphological changes like filamenta-
tion, inhibition of septum formation, spheroplast forma-
tion, as well as lysis and development of abnormally
shaped cells. In vitro the incorporation of diaminopime-
lic acid into the cell wall murein of strain W7, was
inhibited in a dose dependent way [23]. Thymus zygis oil
has also a very strong antibacterial activity tested against
different bacterial species and modulates inflammatory
cytokines like IL-1β, TNFα, IL-6 and IL-10 in vitro [24].
Antioxidative effects of Rosmarinus officinalis leaf oil
have also been described [25].
The aim of this prospective randomized study was to
identify, if the adjunctive use of a mouthwash containing
three essential oils (Cymbopogon flexuosus oil, Thymus
Zygis oil, Rosmarinus officinalis) in the first days follow-
ing SRP can improve the clinical results of SRP and has
effects on the composition of the subgingival biofilm.
Our hypothesis was to test, whether there is a significant
difference between the adjunctive treatment with or
without essential oil mouthwash, regarding changes of
the clinical parameters PD, AL and BOP after 6 months.
Methods
Study design
Following approval of the study by the Ethics Commis-
sion (332-12-24092012, see Additional file 1) of the
Medical Faculty at the University of Leipzig, the volun-
tary participants were recruited from the patient’s pool
of a private dental practice (M.F.). After extensive con-
sultation and signing the informed consent the random-
ized double-blinded study started in April 2013 and
ended in September 2014. The study was conducted in
full accordance with the principles outlined in the
Declaration of Helsinki, as revised in 2000. All treatment
was performed by the same dentist. To avoid bias, an-
other investigator blinded the treatment collected plaque
and assessed the clinical data.
Patients
Patients were included in the study by fulfilling the
following criteria: being between 40 and 65 years old,
having a generalised moderate chronic periodontitis
[26] having a minimum of 20 teeth, probing depth
(PD) between 4 and6 mm, no periodontal treatment
within the past year, and no antibiotic therapy within
the last 6 months. The interproximal plaque index
(API, [27]) was required to be ≤ 35 % after two initial
prophylaxis and instruction sessions. Results of the
API ≤ 35 % reflect a sufficient hygiene to start with
periodontal therapy [27]. Pregnancy, breastfeeding and
allergy to the ingredients of the herbal distillate prod-
ucts were exclusion criteria.
The 50 patients were allocated into a test group con-
sisting of 25 and a control group of 25 participants with
the use of a computer-generated randomization table.
All patients were asked for smoking (non-smokers,
former smokers, smokers.).
The clinical variables PD, attachment level (AL) and
bleeding on probing (BOP) of all teeth were determined
in a six-point measurement per tooth (mesiobuccal, buc-
cal, distobuccal, mesiooral, oral and distooral) with a
manual periodontal probe (PCP-UNC 15, Hu-Friedy
Manufacturing Co., Chicago, IL, USA) at three appoint-
ments: before SRP (baseline), after three and 6 months.
The modified sulcus bleeding index (SBI) was recorded.
At the same time, samples of the subgingival biofilm
were taken at one site per quadrant with PD 4-6 mm.
For sampling of the subgingival biofilm, endodontic
paper points (ISO 60, Roeko GmbH, Langenau,
Germany) were inserted into the pocket until resistance
was felt and were left in place for 15 s. The strips and
points were stored as a pooled sample at -20°C after
sampling and immediately transferred to the laboratory
(Institut Mikroökologie, Herborn, Germany) for analysis.
Therapy and follow-Up treatment
Under local anaesthesia with articaine hydrochloride/
epinephrine hydrochloride (Ultracain D-S, Sanofi-
Aventis, Frankfurt/Main, Germany), the participants re-
ceived full-mouth scaling and root planing (SRP) in two
sessions carried out within 24 h using hand and ultra-
sonic instruments. All patients used a chlorhexidine
digluconate mouthwash (Chlorhexamed forte 0.2 %,
GlaxoSmithKline Healthcare, Bühl, Germany) for one
minute twice daily during the first seven days after SRP
and performed carefully normal oral hygiene with tooth-
brush and interdental brushes.
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At the end of the SRP, the volunteers in the test group
were requested to rinse their oral cavity with Parodo-
lium® mouthwash (SymbioVaccin, Herborn, Germany).
The composition of the mouthrinse was as follows:
Cymbopogon flexuosus oil, Thymus zygis oil, Rosmarinus
officinalis leaf oil, PEG-40-hydrogenated-castor-oils-
emulsifier, aqua (0.5 %, 0.5 %, 0.5 %, 6 %, 92.5 %).
During the first two weeks after SRP the oral cavity
was rinsed with five drops in a glass of water for
sixty second twice daily. In the control group a
blinded placebo provided by the manufacturer was
used for rinsing. The placebo was composed of the
emulsifier and water. The patients were controlled for
exact drug use by a phone call after three and 10 days.
Both mouthwashes were labelled and separately used
by the instructed patient. Appointments of supportive
periodontal therapy took place 3 months after SRP.
Professional tooth cleaning and reinforcement of oral
hygiene were performed.
Microbiological analysis
For microbiological analysis, DNA was extracted and
cleaned using the NucliSENS® easyMag® (Biomerieux,
Nürtingen, Germany) according to the manufacturer’s
description. The analysis was performed using the Paro-
Check® kit (Greiner Bio-One, Frickenhausen, Germany,
Henne et al. 2014 [28]. The test is able to identify up to
20 periodontopathogenic bacterial species after two PCR
runs and a subsequent reverse hybridization. For the study
the following bacteria were analysed semiquantitatively:
Tannerella forsythia, Porphyromonas gingivalis, Trepo-
nema denticola, Prevotella intermedia, Parvimonas micra,
Campylobacter rectus/showae, Fusubacterium nucleatum,
Aggregatibacter actinomycetemcomitans, Eikenella corro-
dens and Actinomyces viscosus.
The results were categorized as follows: category 0
(signal-noise-ratio/SNR: 0–12, negative), category 1
(SNR: 13–21, norm range), category 2 (SNR: 21–40),
category 3 (SNR: 40–200) and category 4 (SNR: >200).
Category 0 and 1 were merged together, being denoted
as category 0–1.
Statistical analysis
The statistical analysis was carried out with assistance of
SPSS, Version 22.0 (SPSS Inc., NY, U.S.A.). The null
hypothesis was that there are no statistically significant
differences between the test and control group, regard-
ing clinical parameters PD, AL and BOP. Change of PD
at the 6-months appointment was set as the primary
outcome and used to determine sample size. A mean
difference of 1 mm in observed PD with a standard devi-
ation of 1 mm between two groups or two examination
dates would require ≥ 16 patients per group in order to
detect a significant difference (p ≤ 0.05) with a test power
of 80 % (GraphPad StatMate v.2.0 for Mac, GraphPad
Software, San Diego, CA, U.S.A.). We started with 25
Patients to compensate for possible dropouts. Secondary
outcome variables were changes of PD after 3 months,
in the number of sites with PD ≥ 5 mm, occurrence of
BOP, mean AL as well as the counts of selected patho-
genic bacteria associated with periodontitis after three
and 6 months. The statistical unit was the individual
patient. For both intra- and inter-group comparisons,
non-parametric tests (Wilcoxon test for paired samples
and Mann Whitney U- test, respectively) and χ2 - test
were used. A level of α ≤ 0.05 was considered as being
significant.
Results
Figure 1 presents the study flow adapted to Moher et al.
[29]. 60 patients were assessed for eligibility, 10 patients
were excluded. There were two drop outs in each group,
these four patients did not attend the second appoint-
ment. Finally, data from 23 patients (11 male, 12 female;
mean age 50.6 years, range 43 – 62 years) in the test
group and data from 23 patients in the control group
(13 male, 10 female, mean age 50.9 years, range 41 –
60 years) were evaluated. The demographic data of these
46 patients are summarized in Table 1. No adverse ef-
fects of the essential oil based mouthwash were observed
during the study. The compliance of the patients was
improved during initial therapy before SRP, API values
of 18% and 21 % were achieved in the test and control
groups, respectively.
The changes of the clinical variables are presented in
Table 2. Significant improvements of AL, PD, BOP and
SBI occurred in both groups after three (p < 0.001) and
6 months (p ≤ 0.015). AL was significantly better in the
test group after 3 and 6 months (2.5 and 2.6 mm vs.
2.8 mm, p < 0.001), so did PD after 3 months in the ten-
dency (p = 0.1). BOP was significantly lower in the test
group after three months (6.0 vs. 9.0, p = 0.027). The im-
provement of BOP was also better in the test group after
three months (p = 0.065). There was no significant dif-
ference between the groups at SBI.
The results for the microbiological analysis are given
in Table 3, which comprises all the 10 investigated
bacteria.
C. rectus was significantly reduced in both groups
after three months (pt = 0.002, pc = 0.012), so did P.
micra (pt = 0.035, pc < 0.001) and T. forsythia (pt =
0.012, pc = 0.008).
T. denticola was also reduced in both groups after
3 months (pt = 0.057, pc = 0.004) but with significantly
higher reduction in the test group, (p = 0.044). F. nucle-
atum was significantly more reduced in the test group
than in the control group after three months (p =
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0.029). After six months T. forsythia was still reduced in
the test group, but not in the control group, with signifi-
cant intergroup comparison (p = 0.039).
Discussion
The aim of the present study was to compare the ef-
fect of the additional use of a mouthwash containing
essential oils after SRP regarding clinical outcome
variables and changes of periopathogenic bacteria of
the subgingival biofilm. To our best knowledge and
as a result of a comprehensive search of the existing
literature such a study does not exist. No unintended
side effect was seen.
The 0-hypothesis can be partly rejected. The adjunct-
ive use of the essential oil containing mouthwash gave
significant better results for AL and BOP as well as for
F. nucleatum and T. forsythia. The results of SRP are in
coincidence with those described by Cobb et al. [3].
Cobb reported a superior result for SRP for the reduc-
tion of PD, AL and BOP as well as stronger reduction of
T. denticola, T. forsythia and F. nucleatum after three or
six months. Mean pocket reduction after SRP is
1.29 mm and the mean attachment level gain is
0.55 mm for pockets with PD = 4–6 mm [3]. Our results
correspond to these finding. The differences of PD and
AL between the groups in our study were about 0.2 mm.
This seems to be low but comparing SRP with or with-
out adjuvant antibiotic therapy or adjuvant chemothera-
peutics the mean differences are between 0.06 mm for
metronidazole and 0.35 mm for chlorhexidine at PD and
0.07 mm and 0.16 mm at AL, respectively, after three
months [30]. Referring to findings in well-treated peri-
odontitis patients where a further attachment loss of
0.04–0.1 mm per year occurred [31], an attachment level
gain of 0.2 mm could be of importance. On the other
hand it is obvious that a mouthwash with several essen-
tial oils the first days after SRP cannot have such a
strong effect as a systemic antibiotic. Using a local anti-
biotic 17 % more pocket reduction and 12 % more
attachment level gain were found in the test group in
comparison to the control group with placebo [32]. The
Table 1 Clinical results at baseline
Variables test control P (U test)
n 23 23
Age (years) 50.6 ± 5.8 50.9 ± 6.9
Males (n) 11 13
Females (n) 12 10
Smoker (n) 8 8
PD (mm) 3.3 ± 0.4 3.3 ± 0.3 0.965
AL (mm) 3.5 ± 0.2 3.4 ± 0.3 0.947
BOP (%) 16.5 ± 4 16.7 ± 5.5 0.724
API (%) 18.3 ± 8.2 21.7 ± 5.6 0.094
SBI (%) 18.7 ± 6.5 18.1 ± 5.6 0.869
Fig. 1 Flowchart (adapted to [29]) of the study analyzing the effect of herbal distillates as an adjunct after SRP
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further improvements of SRP by the adjunctive use of
the Parodolium® mouthwash are within the range of im-
provements by adjunctives to SRP [33].
It is known, that SRP reduces periodontopathogenic
bacteria of the subgingival biofilm. Haffajee et al. [34]
and Cugini et al. [5] reported reductions of P. gingivalis,
T. forsythia and T. denticola while other species like
Actinomyces sp., Capnocytophaga sp., F. nucleatum, S.
mitis and V. parvula increased. A reduction of Gram
negative and an increase of Gram positive bacterial
species are associated with gingival health [35–38]. On
the other hand, reinfections occur after several months
[39, 40], already, which is in comparison to our study
with exception of T. forsythia. The reduction of F.
Table 2 Clinical variables (median, 25 and 75 percentile, mean ± SD at baseline, after 3 and 6 months, differences and statistical
analysis
N test group = 23
N control group = 23




17.0 (13.0, 19.0) ***
16.0 (13.0, 19.0) ***
6.0 (4.0, 9.0) *** ††
9.0 (5.0, 12.0) ***
12.0 (9.0, 14.0) ***
11.0 (8.0, 17.0) ***
10.0 (8.0, 12.0) *** †
9.0 (6.0, 11.0) ***
5.0 (3.0, 8.0) ***
















18.0 (14.0, 23.0) ***
16.0 (14.0, 21.0) ***
12.0 (8.0, 15.0) ***
11.0 (7.0, 15.0) ***
13.0 (11.0, 18.0) ***
13.0 (11.0, 15.0) ***
7.0 (4.0, 11.0) ***
8.0 (4.0, 12.0) ***
4.0 (0.0, 8.0) **
















3.3 (3.1, 3.6) ***
3.2 (3.1, 3.5) ***
2.1 (2.0, 2.2) *** ††
2.2 (2.0, 2.5) ***
2.2 (2.0, 2.3) *** ††
2.3 (2.1, 2.5) ***
1.2 (0.8, 1.2) *** †
1.0 (0.9, 1.5) ***
1.1 (0.8, 1.2) ***
















3.5 (3.3, 3.7) ***
3.5 (3.3, 3.7) ***
2.5 (2.4, 2.6) *** ††
2.8 (2.5, 2.9) ***
2.6 (2.5, 2.7) *** ††
2.8 (2.7, 3.0) ***
0.9 (0.8, 1.1) *** †††
0.7 (0.6, 0.8) ***
0.9 (0.7, 1.0) *** †††















































































































Wilcoxon signed rank test: significant longitudinal changes t3 - t0, t6 - t0 within each group
** 0.01 < p < 0.05, *** p < 0.001
Mann Whitney test between the groups (test-control): †0.05 < p < 0.1, †† 0.01 < p < 0.05, ††† < 0.001
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nucleatum in our study after three months is of import-
ance because the presence of F. nucleatum influences
further colonization of the biofilm by several periopatho-
genic bacteria like P. gingivalis and T. forsythia [41].
The advantage of the additional adjuvant use of
the essential oil based mouthwash arises not only
from the fact, that the results after SRP are only
minimal smaller than those with systemic or local
Table 3 Prevalence (%) of bacteria at baseline, after 3 and 6 months and significance of differences
Species Cat. Baseline 3 months 6 months Sig. Δt0-t3 inter Sig. Δt0-t6 inter Sig. Δt0-t3 intra Sig. Δt0-t6 intra
test control test control test control
N = 23 N = 23 N = 23 N = 23 N = 23 N = 23
A. act. 0-1 82.6 91.3 87 91.3 82.6 91.3 p = 0.156 p = 0.221 pt = 0.625 pt = 0.375















pc = xxx pc = xxx
P. ging. 0-1 60.8 43.5 73.9 60.9 52.1 39.1 p = 0.693 p = 0.849 pt = 0.289 pt = 0.687















pc = 0.109 pc = 1.000
T. dent. 0-1 13 0 30.4 13 4.3 0 p = 0.044 p = 0.224 pt = 0.057 pt = 0.549















pc = 0.004 pc = 1.000
T. fors. 0-1 8.7 4.3 26 13 13 4.3 p = 0.632 p = 0.039 pt = 0.012 pt = 0.754















pc = 0.008 pc = xxx
F. nucl. 0-1 4.3 0 0 4.3 4.3 0 p = 0.029 p = 0.179 pt = 0.344 pt = 1.000















pc = 1.000 pc = xxx
P. micra 0-1 34.7 4.3 52.2 39.1 26.1 13 p = 0.127 p = 0.155 pt = 0.035 pt = 1.000















pc < 0.001 pc = 0.210
C. rectus 0-1 21.7 30.4 56.5 56.5 39.1 39.1 0.507 0.142 pt = 0.002 pt = 0.115















pc = 0.012 pc = 0.227
P. interm. 0-1 65.2 39.1 78.2 56.5 65.2 34.7 p = 0.537 p = 0.605 pt = 0.508 pt = 1.000















pc = 0.039 pc = 0.344
E. corrod. 0-1 52.2 56.5 73.9 78.2 34.7 65.2 p = 0.189 p = 0.364 pt = 1.000 pt = 0.302















pc = 0.146 pc = 0.549
A. viscosus 0-1 21.7 4.3 17.3 21.7 8.7 4.3 p = 0.411 p = 0.067 pt = 0.118 pt = 0.424















pc = 0.210 pc = 0.267
Categories 0 and 1 are summarized and denoted as “0-1”
The depicted significance-values are devided in inter-group (test vs. control) and intra-group (the same group at two different times) comparison
The intragroup significances are devided into those of the test group (pt) and control group (pc)
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antibiotics, but positive antioxidative and immuno-
regulatory changes are described in vitro [24, 42]
and in vivo [25]. Hitherto, the exact mechanisms of
these effects have not be fully understood.
Over the last years, the interest in natural antimi-
crobials has increased and many plants have been
studied for their antimicrobial properties [43]. In an
in vitro study Cymbopogon flexuosus had the highest
tested antimicrobial activity of seven in vitro tested
substances with bactericidal effects against S. aureus
and prevented biofilm formation [21]. However, no
study on immunological effects of Cymbopogon flex-
uosus could be found in the literature. Thymus zygis
has been studied more extensively from an immunological
point of view. In a cellular model with human macro-
phages the gene expression for IL-1β, TNFα and Il-6 was
significantly reduced and anti-inflammatory cytokines like
IL-10 does-dependently highly increased [24]. All these
cytokines are key player in periodontal inflammation.
Thymus zygis has in vitro a proven antibacterial activity
against E. coli, S. enteritidis, S. essen and other bacteria
[42]. Within the few existing literature no results on
immunological effects could be found.
Concerning the question of bias our study design re-
duced such a risk, as the examiner was different from
the clinician performing SRP and the examiner has been
anterior calibrated. The intraexaminer variability was
with 0.18 mm for PD and 0.20 for AL low. The risk of
bias was further reduced by using a placebo in the con-
trol group and blinding of the groups for examiner and
clinician.
Further studies are recommended to generalize these
findings as our study comprised only a small group of
patients. However, within the limits of the study we
observed positive effects especially on AL, BOP as well
as on F. nucleatum and T. forsythia in the subgingival
biofilm in vivo of an additional mouthwash containing
essential oils in improving clinical variables as well as
the composition of the subgingival biofilm in the peri-
odontal pocket. These results indicate that in mild or
moderate periodontitis cases with moderate probing
depths the adjunctive use of the tested mouthwash could
be useful.
Conclusions
The adjuvant use of a mouthwash containing Cymbopo-
gon flexuosus, Thymus zygis and Rosmarinus officinalis
(Parodolium®) has a positive effect on the course of
treatment in moderate chronic periodontitis. In particu-
lar, the significantly higher reduction of BOP and AL
should be highlighted. Furthermore, the antibacterial
effects should be outlined especially on F. nucleatum
and T. forsythia in vivo in the context of well-known
potential disadvantages of antibiotics.
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